1mg, best e pharmacy in India


MRP: Rs. 94544.40 for 1 bottle(s) (50 ML infusion each)
Unfortunately, we don't have any more items in stock
Report Error

Composition for ERBITUX

Cetuximab(100 mg)

food interaction for ERBITUX

alcohol interaction for ERBITUX

pregnancy interaction for ERBITUX

lactation interaction for ERBITUX

It can be taken with or without food, but it is better to take Erbitux 100mg infusion at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Erbitux 100mg infusion may be unsafe to use during pregnancy.
Either animal studies have shown adverse effect on fetus and there are no human studies or studies in human and animals are not available. It should be given only if potential benefits justifies risk to the fetus. Please consult your doctor.
Erbitux 100mg infusion is probably unsafe to use during breastfeeding. Please consult your doctor.


Cetuximab(100 mg)


Erbitux 100mg infusion is used alone or in combination with radiation or other anti-cancer drugs to treat cancer of the head and neck (squamous cell cancer) and colon (large intestine) or rectum (which has spread to other organs of the body).

How it works

Erbitux 100mg infusion is a monoclonal antibody that binds and inhibits a particular protein responsible for growth and spread of cancerous tissue.

Common side effects

Nausea, Liver enzyme increased, Conjunctivitis, Dehydration, Diarrhoea, Intestinal injury, Headache, Decreased calcium level in blood, Decreased magnesium level in blood, Weakness, Infusion site reaction, Loss of appetite, Nasal mucous injury, Skin reaction, Vomiting


No substitutes found

Expert advice for ERBITUX

  • Administration of anti-allergy medication including steroids is mandatory at least one hour before cetuximab infusion.
  • Caution is to be observed while driving or using machinery after taking Cetuximab.
  • Cetuximab may also adversely affect skin and eyes with symptoms like blurred vision, eye pain and dry eye.
  • Frequent monitoring for infections and levels of white blood cells is required, if cetuximab is given with certain other anti-cancer drugs (platinum compounds like cisplatin, carboplatin, oxaliplatin).
  • There is increased risk of occurrence of heart problems if cetuximab is given with certain other anti-cancer drugs (fluoropyrimidines like capecitabine, fluorouracil).
  • Caution is to be observed in case of administering cetuximab to elderly patient with heart problems.

Frequently asked questions for ERBITUX


Q. Is cetuximab a chemotherapy drug?
Cetuximab is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers.

Q. Is cetuximab cytotoxic agent or vesicant or radiosensitizer?
 It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant).
Q. Is cetuximab US FDA approved?
Yes, cetuximab is approved by US FDA in 2009 to treat certain type of cancer of colon, rectum and head-neck cancer.
Q. How is cetuximab administered?
Cetuximab is generally administered by intravenous (IV infusion) route, with or without radiotherapy.
Q. Does cetuximab cause hair loss?
Yes. Cetuximab is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect.
Q. Why does cetuximab cause a rash?
Cetuximab may cause rashes. 

Q. How long does the rash last?
The duration of skin rash depends upon its type and severity. Please consult your doctor for advice.


Content on this page was last updated on 18 April, 2015, by Dr. Varun Gupta (MD Pharmacology)